SHARE-BASED COMPENSATION (SARS Activity) (Details) - Stock Appreciation Rights (SARs) [Member] - USD ($)	12 Months Ended
	Feb. 02, 2019	Feb. 03, 2018
Number of Underlying Shares Outstanding [Roll Forward]
Number of Underlying Shares, Outstanding (in shares)	1,041,867	3,010,720
Number of Underlying Shares, Granted (in shares)	0
Number of Underlying Shares, Exercised (in shares)	(50,190)
Number of Underlying Shares, Forfeited or expired (in shares)	(1,918,663)
Weighted-Average Exercise Price [Roll Forward]
Weighted-Average Exercise Price, Outstanding (in dollars per share)	$ 37.81	$ 49.35
Weighted-Average Grant Date Fair Value, Granted (in dollars per share)	0.00
Weighted-Average Exercise Price, Exercised (in dollars per share)	22.21
Weighted-Average Exercise Price, Forfeited or exercised (in dollars per share)	$ 56.43
Aggregate Intrinsic Value, Outstanding	$ 40,035
Weighted-Average Remaining Contractual Life, Outstanding	3 years 6 months
Number of Underlying Shares, Stock appreciation rights exercisable (in shares)	966,372
Weighted-Average Exercise Price, Stock appreciation rights exercisable (in dollars per share)	$ 39.03
Aggregate Intrinsic Value, Stock appreciation rights exercisable	$ 29,650
Weighted- Average Remaining Contractual Life, Stock appreciation rights exercisable	3 years 3 months
Number of Underlying Shares, Stock appreciation rights expected to become exercisable (in shares)	73,591
Weighted-Average Exercise Price, Stock appreciation rights expected to become exercisable (in dollars per share)	$ 22.21
Aggregate Intrinsic Value, Stock appreciation rights expected to become exercisable	$ 9,675
Weighted-Average Remaining Contractual Life, Stock appreciation rights expected to become exercisable	6 years 2 months